The haematological effects of azathioprine are markedly increased by the concurrent use of allopurinol. Azathioprine is rapidly and extensively metabolised to mercapto- purine. Mercaptopurine is therefore expected to share the interactions of azathioprine.
The dosage of azathioprine or mercaptopurine should be reduced by two-thirds to three-quarters to minimise the risk of toxicity. Despite taking these precautions toxicity may still be seen and very close haematological monitoring is advisable if concurrent use is necessary.
© 2006-2021 Last Updated On: 10/10/2021 (0.01)
Wait 20 seconds...!!!